343 related articles for article (PubMed ID: 37995081)
1. The Role of RIN3 Gene in Alzheimer's Disease Pathogenesis: a Comprehensive Review.
Meshref M; Ghaith HS; Hammad MA; Shalaby MMM; Ayasra F; Monib FA; Attia MS; Ebada MA; Elsayed H; Shalash A; Bahbah EI
Mol Neurobiol; 2024 Jun; 61(6):3528-3544. PubMed ID: 37995081
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease.
Shen R; Zhao X; He L; Ding Y; Xu W; Lin S; Fang S; Yang W; Sung K; Spencer B; Rissman RA; Lei M; Ding J; Wu C
Transl Neurodegener; 2020 Jun; 9(1):26. PubMed ID: 32552912
[TBL] [Abstract][Full Text] [Related]
3. The neuronal-specific isoform of BIN1 regulates β-secretase cleavage of APP and Aβ generation in a RIN3-dependent manner.
Bhattacharyya R; Teves CAF; Long A; Hofert M; Tanzi RE
Sci Rep; 2022 Mar; 12(1):3486. PubMed ID: 35241726
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.
Xu W; Fang F; Ding J; Wu C
Traffic; 2018 Apr; 19(4):253-262. PubMed ID: 29314494
[TBL] [Abstract][Full Text] [Related]
5. Ras and Rab Interactor 3: From Cellular Mechanisms to Human Diseases.
Shen R; Murphy CJ; Xu X; Hu M; Ding J; Wu C
Front Cell Dev Biol; 2022; 10():824961. PubMed ID: 35359443
[TBL] [Abstract][Full Text] [Related]
6. The genes associated with early-onset Alzheimer's disease.
Dai MH; Zheng H; Zeng LD; Zhang Y
Oncotarget; 2018 Mar; 9(19):15132-15143. PubMed ID: 29599933
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
[TBL] [Abstract][Full Text] [Related]
9. The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome.
Drummond E; Kavanagh T; Pires G; Marta-Ariza M; Kanshin E; Nayak S; Faustin A; Berdah V; Ueberheide B; Wisniewski T
Acta Neuropathol Commun; 2022 Apr; 10(1):53. PubMed ID: 35418158
[TBL] [Abstract][Full Text] [Related]
10. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
11. Is Beta-Amyloid Accumulation a Cause or Consequence of Alzheimer's Disease?
Wang S; Mims PN; Roman RJ; Fan F
J Alzheimers Parkinsonism Dement; 2016; 1(2):. PubMed ID: 28815226
[TBL] [Abstract][Full Text] [Related]
12. Genomics of Alzheimer's disease implicates the innate and adaptive immune systems.
Li Y; Laws SM; Miles LA; Wiley JS; Huang X; Masters CL; Gu BJ
Cell Mol Life Sci; 2021 Dec; 78(23):7397-7426. PubMed ID: 34708251
[TBL] [Abstract][Full Text] [Related]
13. How Microglia Manages Non-cell Autonomous Vicious Cycling of Aβ Toxicity in the Pathogenesis of AD.
Seol Y; Ki S; Ryu HL; Chung S; Lee J; Ryu H
Front Mol Neurosci; 2020; 13():593724. PubMed ID: 33328884
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
Kazim SF; Iqbal K
Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease.
Šimić G; Španić E; Langer Horvat L; Hof PR
Prog Mol Biol Transl Sci; 2019; 168():99-145. PubMed ID: 31699331
[TBL] [Abstract][Full Text] [Related]
17. Delivery of Intravenously Administered Antibodies Targeting Alzheimer's Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis.
Tashima T
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214143
[TBL] [Abstract][Full Text] [Related]
18. Emerging Proof of Protein Misfolding and Interactions in Multifactorial Alzheimer's Disease.
Uddin MS; Al Mamun A; Rahman MA; Behl T; Perveen A; Hafeez A; Bin-Jumah MN; Abdel-Daim MM; Ashraf GM
Curr Top Med Chem; 2020; 20(26):2380-2390. PubMed ID: 32479244
[TBL] [Abstract][Full Text] [Related]
19. Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease.
Rajasekhar K; Govindaraju T
RSC Adv; 2018 Jun; 8(42):23780-23804. PubMed ID: 35540246
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches.
Gholami A
Neurosci Lett; 2023 Nov; 817():137532. PubMed ID: 37866702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
